- 2025-09-16 15:18BIM-23190 182153-96-4
- 2025-09-16 15:17BIM-23056 TFA 1426173-61-6
- 2025-09-16 15:17σ1 Receptor ligand 1
- 2025-09-16 15:17Ralmitaront (WHO-11130; RO-6889450; RG-7906) 2133417-13-5
- 2025-09-16 15:17BIM-23056 150155-61-6
- 2025-09-16 15:17σ1 Receptor antagonist 4 362512-81-0
- 2025-09-16 15:17N-Methylphenethylamine hydrochloride 4104-43-2
- 2025-09-16 15:17BIM 23052 133073-82-2
- 2025-09-16 15:17WLB-87848 2839205-09-1
- 2025-09-16 15:172-Phenylpropan-1-amine hydrochloride 20388-87-8
- 2025-09-16 15:17Angiopeptin TFA (Angiopeptin trifluoroacetate) 2478421-60-0
- 2025-09-16 15:17UMB24 1033-69-8
- 2025-09-16 15:17(Rac)-RO5263397 HCL
- 2025-09-16 15:17Alkyne-βAG-TOCA
- 2025-09-16 15:17UKH-1114 2113664-14-3
- 2025-09-16 15:17[Nle8] Somatostatin (1-28) (TFA)
- 2025-09-16 15:17SW116 free base 1036759-00-8
- 2025-09-16 15:17Sigma-2 Radioligand 2 2860554-31-8
- 2025-09-16 15:17[Nle8] Somatostatin (1-28) 84768-30-9
- 2025-09-16 15:17Sigma-1 receptor antagonist 6 1335032-28-4
